Digital Health Leadership Life Science Medical Technology 
Lloyd Price
APRIL 10, 2024
Ministerial Forward Time and time again innovative medical technology (medtech) has advanced our quality of care. Building on the Life Sciences Vision, this government is committed to creating an environment for innovators to thrive and grow. Medtech is a vitally important industry for the UK economy. Subscribe Today!
Digital Health Global
MARCH 16, 2023
The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
DECEMBER 14, 2023
NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced significant developments for the use of artificial intelligence (AI) applied to its proprietary vectorelectrocardiography (VECG) technology, including the addition of new leadership and advisory roles.
Lloyd Price
MARCH 16, 2024
This first-of-its-kind event is being hosted by the Department of Health – Abu Dhabi and aims to be a landmark platform for international collaboration on the future of healthcare and life sciences. Subscribe Today!
Lloyd Price
MAY 5, 2024
Dedicated Facilities: The new EIT Oxford campus includes over 30,000 square meters of research laboratory space, an oncology and wellness clinic, and facilities like AI GPU Supercluster Lab, Drug Design Lab, and Medical Device Lab, specifically dedicated to healthcare technology advancements. Visit www.nelsonadvisors.co.uk
Digital Health Global
OCTOBER 23, 2023
Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. &
Digital Health Global
FEBRUARY 5, 2024
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.
Expert insights. Personalized for you.
60 
Let's personalize your content